Grigoris Trypsianis
Overview
Explore the profile of Grigoris Trypsianis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
54
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Venetsanopoulou A, Kalpourtzi N, Alamanos Y, Gavana M, Vantarakis A, Hadjichristodoulou C, et al.
Rheumatol Int
. 2023 Mar;
43(7):1349-1355.
PMID: 37000296
Rheumatoid arthritis (RA) is considered the most common form of autoimmune arthritis. The disease's prevalence is around 0.5-1% worldwide, but it seems to vary among different populations. The aim of...
2.
Kaskafetou S, Karakosta A, Sypsa V, Kalpourtzi N, Gavana M, Vantarakis A, et al.
BMC Public Health
. 2022 Nov;
22(1):2026.
PMID: 36335324
Background: Although several studies on hepatitis B (HBV), C (HCV) and human immunodeficiency virus (HIV) infection have been conducted in Greece, little is known on the knowledge level of the...
3.
Petrakis V, Rapti V, Akinosoglou K, Bonelis C, Athanasiou K, Dimakopoulou V, et al.
Microorganisms
. 2022 Oct;
10(10).
PMID: 36296225
In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as a standard of...
4.
Stergiou G, Ntineri A, Menti A, Kalpourtzi N, Vlachopoulos C, Liberopoulos E, et al.
Hellenic J Cardiol
. 2022 Oct;
69:1-8.
PMID: 36243397
Background: Greece was recently reclassified from low- to medium-risk country in terms of cardiovascular disease, with 27% of cardiovascular deaths attributed to hypercholesterolemia. EMENO nationwide survey (2013-2016) assessed the epidemiology...
5.
Voulgari P, Venetsanopoulou A, Kalpourtzi N, Gavana M, Vantarakis A, Hadjichristodoulou C, et al.
PLoS One
. 2022 Mar;
17(3):e0264388.
PMID: 35245310
Background: Nationwide data on thyroid disease prevalence in Greece is lacking. Using the national health examination survey EMENO data resources, we aimed to estimate the prevalence of hypothyroidism and hyperthyroidism...
6.
Menti A, Kalpourtzi N, Gavana M, Vantarakis A, Voulgari P, Hadjichristodoulou C, et al.
J Hum Hypertens
. 2021 Apr;
36(4):364-369.
PMID: 33837294
This study aimed to assess the reliability of opportunistic screening programs in estimating the prevalence, treatment, and control rate of hypertension in the general population. Two recent epidemiological surveys obtained...
7.
Makrilakis K, Kalpourtzi N, Ioannidis I, Iraklianou S, Raptis A, Sotiropoulos A, et al.
Diabetes Res Clin Pract
. 2020 Dec;
172:108646.
PMID: 33359752
Aims: To report the results of the first national Health Examination Survey (HES) on the prevalence of diabetes, its pharmacologic treatment and level of control, as well as pre-diabetes in...
8.
Stergiou G, Menti A, Kalpourtzi N, Gavana M, Vantarakis A, Chlouverakis G, et al.
J Hypertens
. 2020 Nov;
39(5):1034-1039.
PMID: 33239548
Objective: The evidence on the epidemiology of hypertension in Greece is limited. The prevalence and control of hypertension was assessed in randomly selected adults of the general population in Greece...
9.
Touloumi G, Karakosta A, Kalpourtzi N, Gavana M, Vantarakis A, Kantzanou M, et al.
BMC Public Health
. 2020 Nov;
20(1):1665.
PMID: 33160307
Background: Nationwide data on cardiovascular risk factors prevalence is lacking in Greece. This work presents the findings of the national health examination survey EMENO (2013-2016) regarding the prevalence of hypertension,...
10.
Pafili K, Trypsianis G, Papazoglou D, Maltezos E, Papanas N
Curr Vasc Pharmacol
. 2018 Aug;
18(1):50-56.
PMID: 30156161
Background: Cardiovascular autonomic neuropathy (CAN) and distal symmetrical sensorimotor polyneuropathy (DSPN) are serious microvascular complications of diabetes mellitus (DM). Their simultaneous development remains disputable. The aim of the present study...